SRA (scavenger receptor A) is a 77 kDa trimeric transmembrane glycoprotein with 6 distinct domains. 15, 16 The collagen-like domain was known to be responsible for receptor interaction with modified lipoproteins. 17 Indeed, SRA is one of the major scavenger receptors responsible for the binding and uptake of oxidized and acetylated forms of low-density lipoproteins (OxLDL and AcLDL) by macrophages and for mediating the formation of foam cells. 16, 18, 19 
A therosclerosis is the primary cause of most cardiovascular diseases, such as coronary artery disease, myocardial infarctions, and strokes. 1 The formation and development of atherosclerotic lesions is a chronic process characterized by the deposition of excessive cholesterol in the arterial intima. As the major component in atherosclerotic lesions, macrophages play a critical role in the development of atherosclerosis. 2 During atherogenesis, circulating monocytes transmigrate into the subintima and differentiate into macrophages that can uptake large amounts of modified lipoproteins through the scavenger receptor pathway. 3 Uncontrolled accumulation of lipoproteins transforms the macrophages into lipid-rich foam cells, which is a hallmark of atherosclerosis and results in lesion expansion. 4 Although the formation of foam cells in the arterial wall has long been recognized as a critical step in the development of atherosclerosis, the molecular mechanisms underlying this process are not fully understood.
LKB1 (liver kinase B1) is a conserved serine/threonine kinase that was first identified as a tumor suppressor responsible for Peutz-Jeghers syndrome. 5, 6 However, expression of LKB1 is ubiquitous in many cell types and tissues, suggesting that LKB1 may be a multifunctional protein. Indeed, LKB1 plays a critical role in embryonic development as global Lkb1 knockout (KO) is embryonically lethal in mice. 7 Various tissue-and cell-specific KO mice models have revealed multiple protective roles of LKB1 in cardiovascular diseases and metabolic disorders. [8] [9] [10] [11] [12] [13] Recently, we have found a novel role of LKB1 in macrophages suppressing lipopolysaccharide-induced inflammation. 14 However, the contribution of LKB1 in atherosclerosis, a chronic inflammatory disease, remains unknown. October 13, 2017 of SRA in the vessel wall is highly induced during cholesterol feeding and the formation of atherosclerotic lesion. 20 However, the underlying mechanism is not completely understood. It has been shown that SRA can be regulated by a variety of stimuli such as modified lipoproteins, macrophage colony-stimulating factor, and lipopolysaccharides at the mRNA level. [21] [22] [23] Recently, it has been reported that the phosphorylation level of SRA is negatively associated with its abundance, 24 suggesting a role for phosphorylation in regulating SRA protein level. Here, we report that by promoting the phosphorylation and consequent lysosomal degradation of SRA, macrophage LKB1 plays a key modulatory role in foam cell formation and the progression of atherosclerosis.
Methods
Macrophage-specific LKB1-deficient mice in an ApoE −/− background were generated by crossing LKB1-floxed mice (LKB1 fl/fl ) with LysM cre transgenic mice and then crossing with ApoE −/− mice to form ApoE For bone marrow transplantation experiments, 8-week-old male Ldlr −/− mice were subjected to 11-Gy lethal total body irradiation (2 doses of 5.5 Gy within an interval of 4 hours) to eliminate endogenous bone marrow stem cells and bone marrow-derived cells. Mice were then retro-orbitally injected with bone marrow cells (5×10 6 ) isolated from wild-type (WT) or macrophage-specific LKB1 KO mice. Mice were allowed to recover for 6 weeks after bone marrow transplantation and then fed a western diet for 18 weeks. Atherosclerotic lesions of thoracic aorta, aortic arch, and aortic root were determined by Sudan IV staining and Oil Red O staining.
Details of materials and experimental procedures are available in the Online Data Supplement.
Results

Expression of LKB1 Is Decreased in Human Atherosclerotic Carotid Artery
To determine the role of LKB1 in the initiation and progression of atherosclerosis, we first measured the expression of LKB1 in human healthy vessels (internal mammary artery) and carotid atherosclerotic plaques. As shown in Figure 1A , LKB1 level is dramatically decreased in atherosclerotic plaques, suggesting an important role of LKB1 in the development of atherosclerotic plaque.
Time-Sensitive Reduction of LKB1 in Western Diet-Fed Atherosclerosis-Prone Mice
To validate this finding, we further examined the expression of LKB1 in atherosclerosis-prone mice that had been fed a western diet for different durations. As shown in Figure 1B , Ldlr −/− mice fed a western diet for 8 weeks showed a 30% reduction in LKB1 protein levels when compared with mice fed a normal chow diet. In mice fed a western diet for 16 weeks, the levels of LKB1 were reduced 70%. The mRNA level of LKB1 was also significantly decreased after 8 weeks of western diet feeding and was further decreased after 16 weeks of western diet feeding ( Figure 1C) .
In another atherosclerosis-prone mice model ApoE −/− mice, LKB1 protein level and mRNA level were also significantly decreased after 5 weeks of western diet feeding and were further decreased after 10 weeks of western diet feeding ( Figure 1D  and 1E ). LKB1 level was further analyzed in atherosclerotic lesions by immunofluorescence staining. As shown in Figure 1F , western diet feeding resulted in massive macrophage accumulation in the atherosclerotic lesion area, whereas LKB1 was dramatically decreased in mice fed a western diet for 16 weeks, especially in the lesion area. All these results suggest a potential role for LKB1 in the development of atherosclerosis.
Downregulation of LKB1 Occurs Markedly in Macrophages Compared With Vascular Smooth Muscle Cells
Macrophages play a prominent role in atherosclerotic plaque formation. 3 To determine whether LKB1 is decreased in 
Novelty and Significance
What Is Known?
• Atherosclerosis is the primary cause of many cardiovascular diseases.
• The serine/threonine protein kinase LKB1 (liver kinase B1) is a wellknown tumor suppressor, which has recently been implicated in cardiovascular diseases.
• SRA (scavenger receptor A) is one of the major scavenger receptors responsible for binding and uptake of oxidized and acetylated forms of lowdensity lipoproteins by macrophages leading to the formation of foam cells.
What New Information Does This Article Contribute?
• LKB1 expression is reduced in macrophages with atherosclerotic progression.
• LKB1 deficiency in myeloid cells promotes foam cell formation and development of atherosclerosis.
• LKB1 phosphorylates SRA and promotes its degradation through the lysosome.
Foam cell formation is crucial for atherosclerosis and fuels the development of vulnerable plaques. We found that the levels of LKB1 are reduced during the development of atherosclerosis and that LKB1 phosphorylates SRA and promotes its degradation by a lysosome-dependent mechanism. These findings reveal an important role of LKB1 in foam cell formation and provide a novel link between LKB1 and atherosclerosis. LKB1 could be a potential therapeutic target for preventing atherosclerotic disease.
macrophages within atherosclerotic plaques, costaining of LKB1 and macrophage marker CD68 was analyzed. As shown in Figure 1F , there was much less costaining of LKB1 and CD68 in mice fed a western diet for 16 weeks than that in mice fed a western diet for 8 weeks, suggesting a potential role of macrophage LKB1 in atherosclerosis development. Vascular smooth muscle cells (VSMCs) are also involved in atherosclerotic foam cell formation. [25] [26] [27] We thus further examined LKB1 expression in VSMCs during the development of atherosclerosis. To this end, LKB1 was costained with SMA (smooth muscle actin), a smooth muscle cell marker. As shown in Online Figure I , costaining of LKB1 and SMA changed little after 8 weeks of western diet feeding.
Macrophage LKB1 Is Downregulated by OxLDL
To further evaluate the effects of atherosclerotic stimuli on LKB1 expression in macrophages and smooth muscle cells, Raw264.7 macrophages, primary peritoneal macrophages, or VSMCs were incubated with OxLDL. As shown in Figure 2A , LKB1 protein level was downregulated to 55% after 12 hours of OxLDL treatment in Raw264.7 macrophages, and it was further decreased to 40% after 24 hours of OxLDL treatment. Quantitative real-time polymerase chain reaction analysis showed that mRNA levels of LKB1 were also downregulated in response to OxLDL in Raw264.7 macrophages in a time-dependent manner ( Figure 2B ). Consistently, in primary macrophages, both protein and mRNA levels of LKB1 were OxLDL is known to induce inducible nitric oxide synthase (iNOS) expression in macrophages, 28, 29 and we had previously found that NO-mediated s-nitrosylation could promote LKB1 degradation. 30 Thus, we first tested whether OxLDL differentially induces iNOS expression in macrophages versus VSMCs. As shown in Online Figure IIIA through IIIC, iNOS expression was robustly induced by OxLDL in Raw264.7 macrophages, whereas iNOS was almost nondetectable in VSMCs. In addition, OxLDL dramatically increased s-nitrosylation of LKB1 in macrophages but not in VSMCs (Online Figure IIID) , suggesting that iNOS induction in macrophages promoted LKB1 degradation.
Macrophage LKB1 Deficiency Promotes Foam Cell Formation
Macrophage-derived foam cell formation is a crucial step in the development of atherosclerosis. Tissue macrophages become foam cells when exposed to chemically modified lipoproteins such as OxLDL and AcLDL. 31 To determine whether macrophage LKB1 deficiency affects foam cell formation, both macrophage cell line Raw264.7 cells and primary bone marrow-derived macrophages (BMDMs) isolated from mice were treated with OxLDL. After the treatments, both Oil Red O staining and filipin staining were performed in OxLDLtreated macrophages.
As shown in Figure 3A through 3C, Raw264.7 cells silenced with LKB1 siRNA showed a significant increase in both Oil Red O staining and filipin staining when compared with those silenced with control siRNA (for siRNA efficiency, Online Figure IV) . Similarly, primary BMDMs from LKB1 KO mice showed higher levels of both Oil Red O staining and filipin staining than their counterparts from WT mice ( Figure 3B through 3D) . These results indicated that LKB1 deficiency dramatically increases the capacity of macrophages to form foam cells.
Macrophage LKB1 Deficiency Increases the Uptake of Modified Lipoproteins
Macrophage foam cells are generated by uncontrolled uptake of modified lipoproteins and impaired cholesterol efflux. 31 Therefore, we next investigated whether the increased uptake of modified LDL and impaired cholesterol efflux could account for the increased foam cell formation in LKB1-deficient macrophages. To this end, uptake of fluorescently labeled AcLDL (Alexa 488-AcLDL) was performed in both Raw264.7 macrophages and BMDMs. As shown in Figure 4A , the uptake of Alexa 488-AcLDL, as indicated by remarkable increase in fluorescence intensity, was significantly higher in LKB1-silenced Raw264.7 cells than in cells transfected with control siRNA. Similarly, primary macrophages isolated from LKB1 KO mice exhibited much more Alexa 488-AcLDL uptake than cells isolated from WT mice ( Figure 4B ). To further confirm these results, we examined the uptake of AcLDL using flow cytometry analysis. As shown in Figure 4C and 4D, the mean fluorescence intensity of AcLDL was significantly higher in both LKB1-deficient Raw264.7 cells and primary BMDMs than in LKB1-positive counterparts, suggesting that LKB1 deficiency promotes AcLDL uptake.
Macrophage LKB1 Deficiency Does Not Affect Its Cholesterol Efflux
Next, we determined whether LKB1 affects cholesterol efflux by performing the cholesterol efflux assay. As shown in Figure 4E and 4F, there is no difference in cholesterol efflux between control and LKB1-deficient macrophages. Together these results suggest that LKB1 deficiency promotes foam cell formation through increased uptake of modified lipoproteins.
LKB1 Deficiency Promotes Lipoprotein Uptake and Foam Cell Formation Through Upregulating SRA
Macrophage scavenger receptors, particularly CD36 and SRA, are the principal receptors responsible for the uptake of modified lipoproteins 32 and have been implicated as factors contributing to early foam cell formation and progression toward more complex vulnerable plaques. 33 As shown in Figure 5A , LKB1 deficiency in Raw264.7 cells significantly increased SRA level while having no effect on CD36 level. Importantly, primary BMDMs showed a similar pattern ( Figure 5B ). We further investigated the abundance of surface SRA and CD36 by using flow cytometry. As shown in Figure 5C and 5D, surface expression of SRA but not CD36 was significantly increased in LKB1-deficient macrophages when compared with WT.
We next determined whether LKB1 deficiency promotes modified lipoprotein uptake and foam cell formation through SRA. AcLDL uptake and foam cell formation were investigated in BMDMs isolated from WT and LKB1 KO mice and preincubated with and without blocking antibody against SRA. As shown in Figure 5E , LKB1-deficient BMDMs had significantly increased uptake of AcLDL, which was abrogated specifically by pre-treatment using SRA blocking antibody. Further, LKB1 deficiency in BMDMs significantly increased foam cell formation as indicated by Oil Red O staining ( Figure 5F ). Pre-treatment with SRA blocking antibody abrogated foam cell formation in LKB1-deficient macrophages. Taken together, these data suggest that LKB1 deficiency promotes modified lipoprotein uptake and foam cell formation through upregulating SRA.
LKB1 Promotes Lysosome Degradation of SRA
Next, we sought to investigate how LKB1 regulates SRA expression in macrophages. LKB1 deficiency increased SRA protein levels ( Figure 5A through 5D ). In contrast, quantitative real-time polymerase chain reaction results showed that LKB1 deficiency in both Raw264.7 macrophages and primary BMDMs did not alter mRNA levels of SRA when compared with control ( Figure 6A and 6B), suggesting that LKB1 regulates SRA post-transcription. Proteasome and lysosome are 2 major systems for intracellular protein degradation. To determine how SRA is degraded, Raw264.7 macrophages were treated with proteasome or lysosome inhibitors. As shown in Figure 6C , treatment of MG132, a potent 26S proteasome inhibitor, did not change SRA level in macrophages. However, inhibition of lysosomal function by bafilomycin A1 (BafA) or chloroquine (CQ) significantly increased SRA levels ( Figure 6D and 6E ). These data indicated that SRA is degraded through a lysosome-dependent pathway.
To further examine whether LKB1 downregulates SRA through the lysosome-dependent pathway, macrophages were overexpressed with LacZ or LKB1 plasmid and then treated with/without lysosomal inhibitors BafA or CQ. As shown in Figure 6F and 6G, overexpression of LKB1 significantly decreased SRA expression, whereas treatment with lysosomal inhibitors BafA or CQ abrogated this decrease. Overall, these results suggest that LKB1 promotes lysosome degradation of SRA.
Phosphorylation of SRA by LKB1 Promotes Its Degradation
Phosphorylation of scavenger receptors can modulate their stability. 34 Specifically, phosphorylation changes in the cytoplasmic domains of these receptors can affect their degradation. 34 As LKB1 is a conserved serine/threonine kinase, we hypothesized that LKB1 may phosphorylate SRA and thus regulate its degradation. To test this hypothesis, SRA from total protein extracts of Raw264.7 macrophages silenced with control or LKB1 siRNA was immunoprecipitated and detected for phosphorylation and total expression of SRA. As shown in Figure 7A , the amount of phosphorylated SRA was much lower in LKB1-silenced macrophages even though more total SRA protein was present, suggesting a decreased phosphorylation of SRA. This result was confirmed in primary BMDMs isolated from WT and LKB1 KO mice ( Figure 7B ). To further investigate whether LKB1 is the upstream kinase of SRA, an in vitro kinase assay was performed. As shown in Figure 7C , LKB1 significantly increased the phosphorylation of SRA, suggesting that LKB1 functions as the upstream kinase and can directly phosphorylate SRA. To further examine whether phosphorylation of SRA by LKB1 regulates its protein stability, SRA protein sequences were analyzed by phosphorylation prediction software GPS 2.1. As shown in Figure 7D , human and mouse SRA sequences showed a conserved LKB1 phosphorylation site in the cytoplasmic domain (Ser-48 and Ser-53 in human and mouse SRA sequences, respectively). We found that SRA expressed by a phosphorylation mouse mutant (serine 53 was replaced with alanine, S53A) was more stable than WT SRA. Conversely, SRA expressed by a phosphomimic mutant (serine was mutated into aspartic acid, S53D) was less stable than the WT SRA ( Figure 7E ), suggesting that the phosphorylation status of SRA at serine 53 affects its protein stability. Next, we examined whether LKB1 regulates SRA degradation through phosphorylation of serine 53. As shown in Figure 7F , overexpression of LKB1 downregulated WT SRA but had no effect on S53A mutant SRA. All these results suggested that phosphorylation of SRA by LKB1 promotes its degradation.
Macrophage LKB1 Deficiency Promotes the Development of Atherosclerosis In Vivo
Finally, to determine the role of macrophage LKB1 in atherosclerosis in vivo, Ldlr −/− mice were transplanted with bone marrow from WT or macrophage-specific LKB1 KO mice and fed a western diet for 18 weeks. As shown in Online Figure  VA through VC, there is no difference in body weight, serum triglyceride, and serum cholesterol levels between Ldlr −/− mice receiving WT and KO bone marrows. However, Ldlr −/− mice receiving LKB1 KO bone marrows developed more lesions in the aortic arch area than those receiving WT bone marrows (Online Figure VD) . Sudan IV staining of aorta showed that mice receiving LKB1 KO bone marrows had a 111% increase in en face thoracic aorta lesion when compared with WT control (Online Figure VE) . Analysis of Oil Red O staining of the aortic root also showed a significant increase (52%) in lesion formation in mice receiving LKB1 KO bone marrows (Online Figure VF) , suggesting a protective role of macrophage LKB1 in the development of atherosclerosis. SRA levels were further detected in the aortic root lesion, and results showed that Ldlr −/− mice receiving LKB1 KO bone marrow had markedly increased SRA expression in aortic root lesion (Online Figure VG) .
To confirm our hypothesis, ApoE −/− LKB1 fl/fl LysM cre mice, which were macrophage-specific KOs of LKB1 in an ApoE −/− background, were generated. These mice, together with ApoE −/− LKB1 fl/fl mice, were fed with western diet for 16 weeks. As shown in Figure 8A 
Discussion
The present study has revealed the essential role of conserved serine/threonine kinase LKB1 in suppressing the development of atherosclerosis. LKB1 is downregulated primarily in macrophages during the development of atherosclerosis, and macrophage LKB1 deficiency decreases phosphorylation and lysosomal degradation of SRA and promotes foam cell formation and the development of atherosclerosis.
Foam cell formation is a hallmark of atherosclerotic lesions through all the stages of this disease. 4 The formation and retention of the lipid-rich macrophages in the lesion area exacerbates the disease and fuels the development of vulnerable plaques. 35, 36 Therefore, strategies targeting the formation of foam cells can slow lesion progression and may serve as a potential adjunctive treatment for standard lipid-lowering therapies. 37 However, the mechanisms controlling foam cell formation during atherosclerotic progression remain incompletely understood. Here, we report that the well-known tumor suppressor, LKB1, functions as a negative regulator in this process. Importantly, we found that LKB1 is downregulated in response to proatherosclerotic stimuli in vitro and during the progression of atherosclerosis. Because of the essential role of LKB1 in protecting against hyperlipidemia-induced atherosclerotic plaque formation, this downregulation of LKB1 may play an important causative role in the progression of atherosclerosis.
The accumulation of lipids is essential for the differentiation of macrophages and the formation of foam cells. SRA A, Body weight of mice were measured. B and C, Serum levels of triglycerides (B) and cholesterol (C) were measured (n=8). D, Representative images of aortic arch regions with white plaques (yellow arrows). E, En face Sudan IV staining of whole aorta. Lesion area was quantified as percentage of total surface area of aorta (n=6 per genotype). F, Oil Red O stained cross sections at the aortic root. Aortic root lesion size was calculated. Lesion area was quantified as percentage of lumen area (n=8 per genotype). G, Immunostaining of SRA (scavenger receptor A) in aortic root lesion (Scale bar, 100 μm, n=6 per genotype; *P<0.05, **P<0.01). October 13, 2017 is one of the most important scavenger receptors expressed on the cell surface of macrophages and has been strongly implicated in pathological lipid deposition. 16 Previously, it has been reported that SRA is highly expressed in the vessel wall during the induction of atherosclerotic lesion formation. 20 However, the underlying mechanism is poorly understood. Our data demonstrate that LKB1 deficiency increases SRA protein levels without corresponding increase in SRA mRNA levels, which suggests that a post-translational regulation is involved. In fact, it has been previously reported that mimicking phosphorylation of human SRA at serine 48 strongly reduces surface SRA expression. 38 Ricci et al 24 also found that phosphorylation level of SRA is negatively associated with its protein abundance. Here, we found that LKB1 functions as the upstream kinase of SRA and can directly phosphorylate SRA and promote its degradation. This regulation of SRA by LKB1 helps to explain the elevated SRA expression in atherosclerotic lesions and provides a novel mechanism for foam cell regulation.
Although both macrophages and smooth muscle cells have been demonstrated to play important roles in foam cell formation and atherosclerotic progression, 3, 25, 27, 31 we found that macrophages are the primary target of proatherosclerotic stimuli for LKB1 loss. OxLDL exposure causes a timedependent downregulation of LKB1 in macrophages, but not in VSMCs. We found that OxLDL can robustly induce iNOS expression in macrophages, which is consistent with a previous report 29 ; however, we cannot detect iNOS expression in VSMCs after OxLDL exposure (Online Figure  II) . We have previously found that NO-mediated s-nitrosylation promotes LKB1 degradation. 30 It is thus possible that OxLDL-induced iNOS expression in macrophages may promote LKB1 degradation through s-nitrosylation, whereas VSMCs, which lack iNOS expression, undergo no such effect. However, it is also possible that increased exposure of macrophages to OxLDL triggers the transcriptional downregulation of LKB1. The underlying mechanisms warrant further investigation.
In summary, the present study has demonstrated a novel role for macrophage LKB1 in preventing the development of atherosclerosis and uncovered a novel mechanism underlying the regulation of SRA. LKB1 phosphorylates SRA and promotes its lysosomal degradation, which results in less modified lipoprotein uptake and foam cell formation. These findings identify the modulation of macrophage LKB1 as a novel approach for reducing atherosclerosis.
